Mariella Cuomo
Overview
Explore the profile of Mariella Cuomo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turco L, Della Monica R, Giordano P, Cuomo M, Biazzo M, Mateu B, et al.
Front Oncol
. 2024 Dec;
14:1458990.
PMID: 39634265
Oncotherapy can shape intestinal microbiota, which, in turn, may influence therapy effectiveness. Furthermore, microbiome signatures during treatments can be leveraged for the development of personalised therapeutic protocols in cancer treatment...
2.
Coppola S, Paparo L, Bedogni G, Nocerino R, Costabile D, Cuomo M, et al.
Int J Obes (Lond)
. 2024 Nov;
49(1):154-155.
PMID: 39533044
No abstract available.
3.
Coppola S, Paparo L, Bedogni G, Nocerino R, Costabile D, Cuomo M, et al.
Int J Obes (Lond)
. 2024 Sep;
49(1):101-108.
PMID: 39289583
Background/objectives: The PREMEDI study was designed to assess the efficacy of nutritional counseling aimed at promoting Mediterranean Diet (MD) during pregnancy on the incidence of overweight or obesity at 24...
4.
Cuomo M, Coretti L, Costabile D, Della Monica R, De Riso G, Buonaiuto M, et al.
Sci Rep
. 2023 Oct;
13(1):18197.
PMID: 37875530
The gut-brain axis involves several bidirectional pathway communications including microbiome, bacterial metabolites, neurotransmitters as well as immune system and is perturbed both in brain and in gastrointestinal disorders. Consistently, microbiota-gut-brain...
5.
Della Monica R, Buonaiuto M, Cuomo M, Pagano C, Trio F, Costabile D, et al.
Cell Death Dis
. 2023 Sep;
14(9):638.
PMID: 37758718
Despite intense research efforts, glioblastoma remains an incurable brain tumor with a dismal median survival time of 15 months. Thus, identifying new therapeutic targets is an urgent need. Here, we...
6.
Improda T, Morgera V, Vitale M, Chiariotti L, Passaro F, Feola A, et al.
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373098
Cell identity is determined by the chromatin structure and profiles of gene expression, which are dependent on chromatin accessibility and DNA methylation of the regions critical for gene expression, such...
7.
A Rare Adult Primary Intracranial Sarcoma, -Mutant Identified by Epigenomic Profiling: A Case Report
Marinelli A, Cuomo M, Franca R, Buonaiuto M, Costabile D, Pagano C, et al.
Brain Sci
. 2023 Feb;
13(2).
PMID: 36831778
Diagnoses of primary malignant mesenchymal brain tumors are a challenge for pathologists. Here, we report the case of a 52-year-old man with a primary brain tumor, histologically diagnosed as a...
8.
De Riso G, Sarnataro A, Scala G, Cuomo M, Della Monica R, Amente S, et al.
NAR Genom Bioinform
. 2023 Jan;
4(4):lqac096.
PMID: 36601577
DNA methylation is an epigenetic mark implicated in crucial biological processes. Most of the knowledge about DNA methylation is based on bulk experiments, in which DNA methylation of genomic regions...
9.
Pagano C, Coppola L, Navarra G, Avilia G, Bruzzaniti S, Piemonte E, et al.
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551529
Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor and is poorly susceptible to cytotoxic therapies. Amplification of the epidermal growth factor receptor (EGFR) and deletion of exons 2...
10.
Montella L, Cuomo M, Del Gaudio N, Buonaiuto M, Costabile D, Visconti R, et al.
Int J Cancer
. 2022 Dec;
153(3):476-488.
PMID: 36479695
Glioblastoma, the most common and heterogeneous tumor affecting brain parenchyma, is dismally characterized by a very poor prognosis. Thus, the search of new, more effective treatments is a vital need....